The following article from CNS Neuroscience & Therapeutics, “Resolvin D1, an Endogenous Lipid Mediator for Inactivation of Inflammation‐Related Signaling Pathways in Microglial Cells, Prevents Lipopolysaccharide‐Induced Inflammatory Responses” by Min‐Xuan Xu, Bing‐Chang Tan, Wei Zhou, Ting Wei, Wei‐Hong Lai, Jing‐Wang Tan and Jia‐Hong Dong, published online on 24 March 2013 in Wiley Online Library (wileyonlinelibrary.com) and in Volume 19, Number 4 (April 2013), pp. 235–243, has been retracted by agreement between the author(s), the journal's Editor in Chief, Ding‐Feng Su, and John Wiley & Sons Ltd. The retraction has been agreed due overlap between this article and “Aspirin‐triggered lipoxin A4 attenuates LPS‐induced pro‐inflammatory responses by inhibiting activation of NF‐KB and MAPKs in BV‐2 microglial cells” by Yan‐Pin Wang, Yan We, Long‐Yan Li, Jin Zheng, Ren‐Gang Liu, Jie‐Ping Zhou, Shi‐Ying Yuan, You Shang and Shang‐Long Yao, Journal of Neuroinflammation, Volume 10, Number 8 (August 2011). doi: 10.1186/1742‐2094‐8‐95.
Reference
Xu MX, Tan BC, Zhou W, Wei T, Lai WH, Tan JW, Dong JH. Resolvin D1, an Endogenous Lipid Mediator for Inactivation of Inflammation‐Related Signaling Pathways in Microglial Cells, Prevents Lipopolysaccharide‐Induced Inflammatory Responses. CNS Neurosci Ther 2013;19(4):235–245. doi: 10.1111/cns.12069.